Scott Bizily, Chief Legal Officer: 4D Molecular Therapeutics FDMT Planned sale · Filed 08/17

Trade details

Type: Planned sale notice
Stock: 4D Molecular Therapeutics FDMT
Person: Scott BizilyChief Legal Officer
Planned sale date: 26/08/17
Filed: 26/08/17

More to sell after $229.3K in 3 months

4D Molecular Therapeutics trades, last 26 weeks

What else happened in 4D Molecular Therapeutics around then

Filed or reported within 30 days of the trade day · 07/18~09/16

Scott Bizily's recent trades

Scott BizilyChief Legal Officer
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan
4D Molecular Therapeutics
FDMT
$19.4K
1,635 sh
$19.4K
Filed 08/13
Traded 08/13
Scott BizilyChief Legal Officer
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan
4D Molecular Therapeutics
FDMT
$84.6K
6,566 sh
$84.6K
Filed 06/30
Traded 06/30
Scott BizilyChief Legal Officer
Sell10b5-1 plan4D Molecular Therapeutics
Sell10b5-1 plan
4D Molecular Therapeutics
FDMT
$117.7K
9,810 sh
$117.7K
Filed 06/25
Traded 06/23
Scott BizilyChief Legal Officer
Planned sale10b5-1 plan4D Molecular Therapeutics
Planned sale10b5-1 plan
4D Molecular Therapeutics
FDMT
$102.2K
9,810 sh
$102.2K
Filed 06/23
Traded 06/23
Scott BizilyChief Legal Officer
Sell10b5-1 plan4D Molecular Therapeutics
Sell10b5-1 plan
4D Molecular Therapeutics
FDMT
$17.8K
1,635 sh
$17.8K
Filed 25/12/19
Traded 25/12/16